Updated on 6 October 2026
LumbaCure®: Take low back pain rehabilitation to the next level
CEO and Co-founder at ODIX
Liege, Belgium
About
Low Back Pain (LBP) is the leading cause of disability worldwide, limiting mobility, productivity, and quality of life (WHO, 2018). The cost of the pathology is estimated in UK to £13B share in healthcare costs & productivity losses. Though physical therapy is the recommended first-line treatment, its outcomes are often inconsistent.
To address this unmet need, ODIX developed LumbaCure® — a clinically proven robotic seat that actively mobilizes the lower back, alleviates stiffness, and re-engages patients in pain-free movement. With six degrees of freedom and a seated design, LumbaCure® integrates easily into multidisciplinary rehab programs. In a randomized clinical trial, it improved recovery rates by up to 4x within a back school setting and enabled physiotherapists to treat more patients effectively. We create value for clinics, physiotherapists & patients.
We are looking for strategic partnering with Distributors all over Europe-
Similar opportunities
Partnership
We are seaking for distribution partners within the main EU countries and abroad.
- Business
Xavier Delcorps
Chief Commercial Officer at ODIX
Liège, Belgium
Service
White-label VR patient simulations and AI virtual patients for training
- E-HEALTH
- THERAPEUTIC AREA
- Education, Training & Qualifying
Radomir Kucharski
CEO at Kucharski Consulting sp. z o.o.
Katowice, Poland